Literature DB >> 28262505

Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.

Ka Lung Cheung1, Fan Zhang2, Anbalagan Jaganathan1, Rajal Sharma1, Qiang Zhang3, Tsuyoshi Konuma1, Tong Shen1, June-Yong Lee4, Chunyan Ren1, Chih-Hung Chen5, Geming Lu6, Matthew R Olson7, Weijia Zhang8, Mark H Kaplan7, Dan R Littman9, Martin J Walsh10, Huabao Xiong6, Lei Zeng3, Ming-Ming Zhou11.   

Abstract

The BET proteins are major transcriptional regulators and have emerged as new drug targets, but their functional distinction has remained elusive. In this study, we report that the BET family members Brd2 and Brd4 exert distinct genomic functions at genes whose transcription they co-regulate during mouse T helper 17 (Th17) cell differentiation. Brd2 is associated with the chromatin insulator CTCF and the cohesin complex to support cis-regulatory enhancer assembly for gene transcriptional activation. In this context, Brd2 binds the transcription factor Stat3 in an acetylation-sensitive manner and facilitates Stat3 recruitment to active enhancers occupied with transcription factors Irf4 and Batf. In parallel, Brd4 temporally controls RNA polymerase II (Pol II) processivity during transcription elongation through cyclin T1 and Cdk9 recruitment and Pol II Ser2 phosphorylation. Collectively, our study uncovers both separate and interdependent Brd2 and Brd4 functions in potentiating the genetic program required for Th17 cell development and adaptive immunity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRD2; BRD4; CTCF; Th17 cell differentiation; gene transcription; the cohesin complex

Mesh:

Substances:

Year:  2017        PMID: 28262505      PMCID: PMC5357147          DOI: 10.1016/j.molcel.2016.12.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  52 in total

1.  The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.

Authors:  A C Bell; A G West; G Felsenfeld
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

Review 2.  Journey through the thymus: stromal guides for T-cell development and selection.

Authors:  Yousuke Takahama
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

3.  STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.

Authors:  Xuexian O Yang; Athanasia D Panopoulos; Roza Nurieva; Seon Hee Chang; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

4.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

5.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

Review 6.  Multidimensional heteronuclear nuclear magnetic resonance of proteins.

Authors:  G M Clore; A M Gronenborn
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

8.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

9.  The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.

Authors:  Tieying Hou; Sutapa Ray; Chang Lee; Allan R Brasier
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

View more
  46 in total

Review 1.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.

Authors:  Andrew Antolic; Hiroko Wakimoto; Zhe Jiao; Joshua M Gorham; Steven R DePalma; Madeleine E Lemieux; David A Conner; Da Young Lee; Jun Qi; Jonathan G Seidman; James E Bradner; Jonathan D Brown; Saptarsi M Haldar; Christine E Seidman; Michael A Burke
Journal:  JCI Insight       Date:  2020-08-06

3.  The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Authors:  Dorothy C C Wai; Taylor N Szyszka; Amy E Campbell; Cherry Kwong; Lorna E Wilkinson-White; Ana P G Silva; Jason K K Low; Ann H Kwan; Roland Gamsjaeger; James D Chalmers; Wayne M Patrick; Bin Lu; Christopher R Vakoc; Gerd A Blobel; Joel P Mackay
Journal:  J Biol Chem       Date:  2018-03-22       Impact factor: 5.157

Review 4.  Chromatin dependencies in cancer and inflammation.

Authors:  Ivan Marazzi; Benjamin D Greenbaum; Diana H P Low; Ernesto Guccione
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-29       Impact factor: 94.444

5.  GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.

Authors:  Samantha M Bevill; Jose F Olivares-Quintero; Noah Sciaky; Brian T Golitz; Darshan Singh; Adriana S Beltran; Naim U Rashid; Timothy J Stuhlmiller; Andrew Hale; Nathaniel J Moorman; Charlene M Santos; Steven P Angus; Jon S Zawistowski; Gary L Johnson
Journal:  Mol Cancer Res       Date:  2019-04-18       Impact factor: 5.852

6.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

7.  The Bromodomain Protein 4 Contributes to the Regulation of Alternative Splicing.

Authors:  Sheetal Uppal; Anne Gegonne; Qingrong Chen; Petria S Thompson; Dan Cheng; Jie Mu; Daoud Meerzaman; Hari S Misra; Dinah S Singer
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

Review 8.  Bromodomain biology and drug discovery.

Authors:  Nilesh Zaware; Ming-Ming Zhou
Journal:  Nat Struct Mol Biol       Date:  2019-10-03       Impact factor: 15.369

9.  Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

Authors:  Shaokun Shu; Hua-Jun Wu; Jennifer Y Ge; Rhamy Zeid; Isaac S Harris; Bojana Jovanović; Katherine Murphy; Binbin Wang; Xintao Qiu; Jennifer E Endress; Jaime Reyes; Klothilda Lim; Alba Font-Tello; Sudeepa Syamala; Tengfei Xiao; Chandra Sekhar Reddy Chilamakuri; Evangelia K Papachristou; Clive D'Santos; Jayati Anand; Kunihiko Hinohara; Wei Li; Thomas O McDonald; Adrienne Luoma; Rebecca J Modiste; Quang-De Nguyen; Brittany Michel; Paloma Cejas; Cigall Kadoch; Jacob D Jaffe; Kai W Wucherpfennig; Jun Qi; X Shirley Liu; Henry Long; Myles Brown; Jason S Carroll; Joan S Brugge; James Bradner; Franziska Michor; Kornelia Polyak
Journal:  Mol Cell       Date:  2020-05-15       Impact factor: 17.970

10.  Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.

Authors:  Michael D Olp; Nan Zhu; Brian C Smith
Journal:  Biochemistry       Date:  2017-10-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.